Effect of Dental Pulp Stem Cells and L-PRF After Impacted Third Molar Extraction
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04641533 |
Recruitment Status :
Completed
First Posted : November 24, 2020
Last Update Posted : November 24, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stem Cell Third Molar Periodontal Pocket | Procedure: L-PRF + DPSC Procedure: L-PRF | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 13 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Intervention Model Description: | Prospective within person randomised split-mouth study. Left and right surgical sites for each participant were randomized using an online generated list to determine test and positive control LM3. (http://www.randomization.com). LM2s and LM3 extraction sockets were divided into two groups: a test group (extraction sockets filled with L-PRF membranes + DPSCs) and a control group (extraction sockets filled with L-PRF membranes). |
Masking: | Double (Investigator, Outcomes Assessor) |
Masking Description: | The random allocation list was generated by a periodontist (EEA), a clinical staff enrolled patients according to their reference date. The first allocation on the list was assigned to the right mandibular molar for each patient by the oral surgeon (SÇ). |
Primary Purpose: | Prevention |
Official Title: | Effect of Dental Pulp Stem Cells and L-PRF Placed Into the Extraction Sockets of Impacted Mandibular Third Molars on the Periodontal Status of Adjacent Second Molars: a Split Mouth Randomised Controlled Clinical Trial |
Actual Study Start Date : | January 20, 2018 |
Actual Primary Completion Date : | April 10, 2020 |
Actual Study Completion Date : | August 11, 2020 |
Arm | Intervention/treatment |
---|---|
Experimental: L-PRF + DPSC
Mandibular third molars were extracted and DPSC with L-PRF placed into the socket.
|
Procedure: L-PRF + DPSC
After surgical removal of impacted mandibular third molars, extraction sockets were filled with L-PRF membranes + DPSCs.
Other Name: Leukocyte platelet rich fibrin plus dental pulp stem cells |
Active Comparator: L-PRF
Mandibular third molars were extracted and L-PRF placed into the socket
|
Procedure: L-PRF
After surgical removal of impacted contralateral mandibular third molars, each extraction sockets were only filled with L-PRF membranes.
Other Name: Leukocyte platelet rich fibrin |
- Probing pocket Depth (PPD) [ Time Frame: 6 months ]Probing pocket Depth (PPD) is the distance between gingival margin and bottom of the periodontal pocket in mm.
- Clinical attachment level (CAL) [ Time Frame: 6 months ]Clinical attachment level (CAL) is the distance between cemento-enamel junction and bottom of the periodontal pocket in mm.
- Radiographic vertical distance [ Time Frame: 6 months ]The cementoenamel junction (CEJ) and the most coronal point of the alveolar bone were identified (AC) on the mesial and distal of lower second molars on digital panoramic radiographs. The vertical ruler on each digital image was used to calibrate the image and to convert measurements from pixels to millimeters with ImageJ. The vertical distance (VD) between cemento-enamel junction and alveolar crest of the lower second molar was than measured with "straight line" tool of the software. In order to calculate the real distance; ertical distance was divided to the magnification factor for panoramic image (1.2).
- Relative bone density (rBD) [ Time Frame: 6 months ]For every extraction socket, a region of interest (ROI) is created for the socket region and one for the surrounding bone using the "Freehand Selection" tool of ImageJ software on panoramic radiographs. Mean grey values were recorded for each group and relative bone density (rBD) was calculated.
- Post-operative pain as assessed by visual analogue scale (VAS) [ Time Frame: 7 days ]Self-reported pain measured in a 100 mm visual analogue scale (VAS) in which (0) denoted "no pain" and 100 meant "severe pain" was recorded at the end of the surgery and 7 days after extraction.
- Assessment of analgesic usage [ Time Frame: 7 days ]The patients were asked to note the amount of analgesics within the post-operative 7 days.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 30 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients aged between 18 and 30 years
- Bilateral impacted LM3 extraction surgeries requirement
Exclusion Criteria:
- Having clinical signs or symptoms of abscess or cellulitis formation
- Having a history of radiotherapy
- Having any systemic diseases interfering with wound healing and/or smokers
- Patients who had been diagnosed as periodontitis
- Patients who had LM2s with caries or restorations that have an unidentifiable cementoenamel junction
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04641533
Turkey | |
Baskent University | |
Ankara, Turkey, 06540 |
Study Director: | Emine Alaaddinoğlu, Prof,PhD | Baskent University |
Responsible Party: | Secil Cubuk, Assist Prof, Baskent University |
ClinicalTrials.gov Identifier: | NCT04641533 |
Other Study ID Numbers: |
SecilC |
First Posted: | November 24, 2020 Key Record Dates |
Last Update Posted: | November 24, 2020 |
Last Verified: | November 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
dental pulp stem cell third molar Platelet-rich fibrin |
Periodontal Pocket Stomatognathic Diseases Periodontitis Periodontal Diseases Mouth Diseases |